Company intelligence

Gyros Protein Technologies

Leading provider of peptide synthesis and bioanalytical tools for biotherapeutics, cell & gene therapies, and vaccines

Biotechnology Research
Uppsala, SE
51–200 employees
Founded 2000
6 public signals

About Gyros Protein Technologies

Gyros Protein Technologies provides enabling peptide synthesis and immunoassay bioanalytical tools that help scientists increase biomolecule performance and productivity in research, drug discovery, pre-clinical and clinical development, and bioprocess applications. With a large and growing installed base of instruments for nanoliter scale immunoassay automation (Gyrolab® xPand and Gyrolab xPlore™), and peptide synthesis (PurePep® Chorus, Symphony® X and PurePep® Sonata®+) in the biopharmaceutical industry and related markets, the solutions from Gyros Protein Technologies accelerate discovery, development, and manufacturing of safer and more efficacious biotherapeutics, cell & gene therapies and vaccines. Gyros Protein Technologies is a division of Mesa Laboratories.

Verified activity

Signals from Gyros Protein Technologies

6 published signals

Log in to see more signals

Find the companies already in motion.

Customize signals around your market, buyers, competitors, and investment thesis.

© 2026 SeedOpsCompany intelligence.

SeedOps.

Gyros Protein Technologies Company Signals | SeedOps